Vanta Bioscience Ltd IPO

Add to Calendar 2017-09-25 12:00 AM 2017-09-27 12:00 AM Asia/Kolkata Vanta Bioscience Ltd IPO Vanta Bioscience Ltd India

Vanta Bioscience Limited (VBS) is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele. Company is headquartered in the USA and operating out of Chennai, India (Research Facility). VBS has 56,000 sq. ft. state of art facilities for conducting various pre-clinical studies and allied research.

Date of establishment: Vanta Bioscience Limited was incorporated in 1995

Product & Service Offering: Company provides safety assessment services for client. They also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.

 

Promoters of Vanta Bioscience: The promoters of the company are:

1. Mohan Krishna Mulakala,
2. Dopesh Raja Mulakala,
3. Dr Vyasmurti Madhavrao Shingatgeri,
4. Dr. Soumya Simhadri,
5. Shravan Chintapatla,
6. Karishma Mulakala,
7. Sajan Kiran Mulakala,
8. Pradeep Chowdary and
9. Dr. Chandrasekhar Rao Simhadri

Customer segment: The company offers its services to clients in Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. 

Objects of the Issue: The objects of the Offer is to:-
-     To meet additional Working Capital Requirement
-     To meet General Corporate Purpose 

Issue Detail

  • Issue Open: Sep 25, 2017
  • Issue Close: Sep 27, 2017
  • Issue Type: Fixed Price Issue IPO
  • Face Value: Rs 10 Per Equity Share
  • Price Band: Rs 50 Per Equity Share
  • Bid Lot:3000 Shares
  • Minimum Order Quantity:3000 Shares
  • Listing At: BSE SME
  • Issue Size: • Rs 7.56 Cr

Current Bidding Status

Number of Times Subscribed (BSE + NSE)
As on Date & Time QIB NII RII Employee Others Total
Day 0 - Sep 25, 2017IST 0 84,000 162,000 - - 246,000
Day 1 - Sep 26, 2017IST 0 171,000 300,0 171,000 300,000 - - 471,000
Day 2 - Sep 27, 2017IST 21,000 1,149,000 978,000 - - 2,148,000

Listing Day Trading Information

- BSE NSE
Issue Price Rs 50.00 -
Open Rs 51.10 -
Low Rs 50.00 -
High Rs 53.85 -
Last Trade Rs 50.20 -
Volume 132,000 -

Vanta Bioscience Ltd Red Herring Prospectus

Vanta Bioscience Ltd User Rating

Votes
0

Vanta Bioscience Ltd Life IPO Reviews

Vanta Bioscience Ltd IPO News & Updates

Frequently Asked Questions

Yes, you can always trade an IPO through a discount broker. Buying & selling an IPO becomes very easy once the trading and the demat account are set up appropriately.
Following are the benefits in buying and selling an IPOs through a discount broker. Reduced Brokerage Fee: Discount brokers charge a flat brokerage which is missing in case of full service brokers. Full service brokers usually charge %age brokerage and this incurs a lot of cost to an investors. So if any full service broker charge a brokerage of let say 0.03% then on a purchase of shares of worth of Rs 200,000 you end up paying Rs 600+ Taxes. In our case we charge a flat brokerage of Rs 20 + Taxes. Discount brokers therefore saves a lot of money of investors. Better Trading Platform: Usually discounts brokers don’t provide a good trading platform and experience but there are few discounts brokers like Samco, who are now focussing on delivering a world class trading platform and top notch user experience. Therefore narrowing down the gap between discount brokers and full service brokers.
Technically Speaking, SEBI has made mandatory to buy an IPO through ASBA channel but there is no regulation on how any investor can sell an IPO allotted shares. Therefore, smart investors can always sell IPO allotted shares through a discount broker

Comments

Start IPO Trading through SAMCO

Don't have a Trading Account !!!
Open an account with Samco and Do IPO Trading for Just Rs 20. For more details, share your contact details with us